Biomagnetics Diagnostics Corporation Initiating Clinical Trials for Integrated Optical Biosensor to Detect Malaria and Tuberculosis in Multiple Markets, Including Kenya, India and is in Talks to Initiate in Mexico

SAN FRANCISCO, Jan. 28, 2010 (GLOBE NEWSWIRE) -- Biomagnetics Diagnostics Corp. (Pink Sheets:BMGP), a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, announced today that the Company is initiating several clinical trials in multiple markets, including Kenya and India, and is also in talks with one of the largest hospitals within the social security system of Mexico in order to address the clinical requirements of that market.